Literature DB >> 23057985

Pharmacological treatment of schizophrenia.

Ary Gadelha1, Cristiano Souza Noto, Jair de Jesus Mari.   

Abstract

BACKGROUND: A lack of human and financial resources, as well as effective health systems, leads to a worldwide treatment gap for schizophrenia. The aim of this paper is to propose evidence-based antipsychotics interventions for people with schizophrenia with special focus in low and middle income countries (LAMIC) reality.
METHOD: A comprehensive search was conducted to locate the main clinical trials, reviews and relevant meta-analyses, and a number of the main recent international clinical practice guidelines.
RESULTS: First- and second-generation antipsychotics are similarly effective in the acute treatment of psychotic symptoms. In LAMIC, the treatment of choice for medical treatment of psychotic conditions is the group of so-called 'first generation antipsychotics' (FGAs) preferentially delivered in a community-based service model.
CONCLUSIONS: Although the symptomatic control is essential, it is not the ultimate goal of treatment. The main aim of treatment is to improve functional recovery and social reintegration of patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23057985     DOI: 10.3109/09540261.2012.703643

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  1 in total

1.  Defining happiness for young adults with schizophrenia: a building block for recovery.

Authors:  Helen T Buckland; Karen G Schepp; Kristen Crusoe
Journal:  Arch Psychiatr Nurs       Date:  2013-08-30       Impact factor: 2.218

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.